Design, Synthesis, and Biological Activity of l-1'-Homologated Adenosine Derivatives.

On the basis of the previously reported polypharmacological profile of truncated d-1'-homologated adenosine derivatives [J. Med. Chem.2020, 63, 16012], the l-nucleoside analogues were synthesized using computer-aided design and evaluated for biological activity. The target molecules were synthesized from d-ribose via the key intramolecular cyclization of the monotosylate and Mitsunobu condensation. The peroxisome proliferator-activated receptor (PPAR) binding activities of l-nucleoside analogue 2d (K i = 4.3 μM for PPARγ and 1.0 μM for PPARδ) were significantly improved in comparison with those of the d-nucleoside compound 1 (11.9 and 2.7 μM, respectively). In addition, the l-nucleosides showed more potent adiponectin-secretion-promoting activity than the d-nucleoside analogues.

[1]  Ji Won Kim,et al.  Discovery and Structure-Activity Relationships of Novel Template, Truncated 1'-Homologated Adenosine Derivatives as Pure Dual PPARγ/δ Modulators. , 2020, Journal of medicinal chemistry.

[2]  Maximilian Kuhn,et al.  Assessment of Binding Affinity via Alchemical Free-Energy Calculations , 2020, J. Chem. Inf. Model..

[3]  G. Miller,et al.  Recent Advances in the Chemical Synthesis and Evaluation of Anticancer Nucleoside Analogues , 2020, Molecules.

[4]  M. Minden,et al.  Novel L-nucleoside analog, 5-fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia , 2019, Haematologica.

[5]  N. Tan,et al.  Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence , 2019, International journal of molecular sciences.

[6]  M. Bauer,et al.  Electrostatic Complementarity as a Fast and Effective Tool to Optimize Binding and Selectivity of Protein-Ligand Complexes. , 2019, Journal of medicinal chemistry.

[7]  S. Suh,et al.  Structural Basis for the Enhanced Anti-Diabetic Efficacy of Lobeglitazone on PPARγ , 2018, Scientific Reports.

[8]  K. Jacobson,et al.  Polypharmacology of N6-(3-Iodobenzyl)adenosine-5'-N-methyluronamide (IB-MECA) and Related A3 Adenosine Receptor Ligands: Peroxisome Proliferator Activated Receptor (PPAR) γ Partial Agonist and PPARδ Antagonist Activity Suggests Their Antidiabetic Potential. , 2017, Journal of medicinal chemistry.

[9]  M. Bowman,et al.  Structural basis for specific ligation of the peroxisome proliferator-activated receptor δ , 2017, Proceedings of the National Academy of Sciences.

[10]  Fabien Zoulim,et al.  Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases , 2013, Nature Reviews Drug Discovery.

[11]  Michael J. Keiser,et al.  Predicting new molecular targets for known drugs , 2009, Nature.

[12]  E. Balaraman,et al.  Mitsunobu and related reactions: advances and applications. , 2009, Chemical reviews.

[13]  C. Mathé,et al.  L-nucleoside enantiomers as antivirals drugs: a mini-review. , 2006, Antiviral research.

[14]  Andy Vinter,et al.  Molecular Field Extrema as Descriptors of Biological Activity: Definition and Validation , 2006, J. Chem. Inf. Model..

[15]  G. Maga,et al.  Antivirals at the mirror: the lack of stereospecificity of some viral and human enzymes offers novel opportunities in antiviral drug development. , 2003, Current drug targets. Infectious disorders.

[16]  H. Choo,et al.  L-nucleosides: antiviral activity and molecular mechanism. , 2002, Current topics in medicinal chemistry.

[17]  Khalil Bennis,et al.  A new route to some enantiomerically pure substituted morpholines from d-ribono- and d-gulono-1,4-lactones , 1994 .

[18]  O. Mitsunobu,et al.  Preparation of Esters of Carboxylic and Phosphoric Acid via Quaternary Phosphonium Salts , 1967 .

[19]  F. Šorm,et al.  Nucleic acids components and their analogues. LIII. Preparation of 1-2'-deoxy-β-L-ribofuranosylthymine, L-thymidine , 1964 .